Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: The University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 5, 2001, Pages 1172-1180

  Nguyen Tan, Phuc F ^a,c   Le, Quynh Thu ^b   Quivey, Jeanne Marie ^a   Singer, Mark ^a   Terris, David J ^b   Goffinet, Don R ^b   Fu, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

Advanced laryngeal carcinoma; Hemoglobin; Prognostic factors; Survival; Treatment

Indexed keywords

CELLS; CHEMOTHERAPY; HEMOGLOBIN; SURGERY; TUMORS;

LOCOREGIONAL FAILURES; PROGNOSIS;

PATIENT TREATMENT;

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOTTIS; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RELAPSE; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035425303     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01538-3     Document Type: Article

References (46)

1. Multidisciplinary management controversies in laryngeal cancer
2. Controversies in the management of laryngeal cancer: Results of an international survey of patterns of care
3. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?
4. Non-Parametric estimation from incomplete observations
5. Regression models and life-tables
6. Management of stage T3 and T4 glottic carcinomas
7. Treatment of carcinoma of the vocal cord. A review of 20 years experience
8. Management of advanced glottic carcinomas
9. Prognostic factors in T3, N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy
10. Treatment of T3 carcinoma of the larynx by surgery or radiotherapy
11. Cancer cure with organ preservation using radiation therapy
12. Treatment decisions in T3N0M0 glottic carcinoma
13. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications
14. Irradiation alone for supraglottic carcinoma: Can CT findings predict treatment results?
15. Management of advanced glottic cancer. A 10 year review of the Toronto experience
16. Supraglottic laryngeal carcinoma: An analysis of dose-time volume factors in 410 patients
17. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: A comparison limited to patients eligible for surgery
18. Stage T3 squamous cell carcinoma of the glottic larynx. A comparison of laryngectomy and irradiation
19. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone
20. T4 laryngeal carcinoma. Radiotherapy alone with surgery reserved for salvage
21. Carcinoma of the supraglottic larynx: A basis for comparing results of radiotherapy and surgery
22. The primary treatment of advanced vocal cord cancer: Laryngectomy or radiotherapy?
23. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation, and two variants of accelerated fractionation to standard fractionation radiotherapy for head, and neck squamous cell carcinoma; first report of RTOG 9003
24. Induction chemotherapy plus radiation therapy compared with surgery plus radiation in patients with advanced laryngeal cancer
25. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analysis of updated individual data. Meta-Analysis of chemotherapy on head and neck cancer
26. Larynx preservation trials: A critical appraisal
27. Recursive partitioning analysis of 2105 patients treated in the Radiation Therapy Oncology Group studies of head and neck cancer
28. Precisely defining high-risk operable head and neck tumors based on RTOG 85-03 and 88-24: Targets for post-operative radiochemotherapy?
29. Management of carcinoma of the supraglottic larynx: Evolution, current concepts, and future trends
30. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma; a secondary analysis of RTOG 8527
31. T1/T2 glottic cancer managed by external beam radiotherapy. The influence of pretreatment hemoglobin on local control
32. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience
33. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
34. The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation
35. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx
36. Erythropoietin for patients undergoing radiotherapy: A pilot study
37. Larynx preservation using induction chemotherapy in advanced but resectable head and neck cancer
38. Larynx preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience
39. Randomized trial of induction chemotherapy in larynx carcinoma
40. Functional outcomes following treatment of advanced laryngeal cancer. Part I- Voice preservation in advanced laryngeal cancer. Part II- Laryngectomy and rehabilitation: The state of the art in the VA System
41. Impact of radiotherapy on second primary cancer risk in patients treated for laryngeal cancer: A population based study
42. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma
43. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy